ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 661

Co-Localization of C-Reactive Protein, Immunoglobulin G and Complement in Renal Subendothelial Immune Deposits of Proliferative Lupus Nephritis Detected Using Immunogold Electron Microscopy

Christopher Sjöwall1, Anders I. Olin2, Thomas Skogh3, Jonas Wetterö4, Mattias Mörgelin2, Ola Nived5, Gunnar Sturfelt6 and Anders A. Bengtsson7, 1Deparment of clinical and experimental medicine, Linkoping University, Linkoping, Sweden, 2Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden, Lund, Sweden, 3Deparment of clinical and experimental medicine, Linköping University, Linköping, Sweden, 4Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, 5Department of Rheumatology, University Hospital Lund, Lund, Sweden, 6Department of Clinical Sciences Lund, Section of Rheumatology, Lund University, Lund, Sweden, 7Department of Clinical Sciences, Section of Rheumatology, Lund University, Lund, Sweden

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: autoantibodies, C-reactive protein (CRP), C1q, lupus nephritis and systemic lupus erythematosus (SLE)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Systemic Lupus Erythematosus - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose: The pattern recognition molecules C-reactive protein (CRP) and complement protein 1q (C1q) are pivotal parts of the innate immune system and display relevant biological functions in the pathogenesis of systemic lupus erythematosus (SLE). Circulating autoantibodies directed against CRP and C1q are frequently found in SLE patients with active disease, especially those with lupus nephritis, and raised serum autoantibody levels reportedly relate to both disease activity and prognosis. This study was performed to assess glomerular localization of IgG, CRP and C1q as a reflection of nephritogenic immune complexes (ICs) in patients with active diffuse proliferative lupus nephritis.

Methods: Renal specimens from five well-characterized patients with active diffuse proliferative lupus nephritis were examined by immunogold electron microscopy to pinpoint glomerular localization of CRP, C1q, C3c and double-stranded (ds) DNA in relation to IgG. Renal biopsies from patients with Henoch-Schönleins purpura, pauci-immune nephritis and renal cancer served as controls. In addition, serum IgG class antibodies against CRP, C1q, and nucleosomes were analyzed by ELISA in the lupus nephritis patients before, during and after renal flares. Informed consent was obtained from all subjects and the research protocol was approved by the Regional Ethics Committee in Lund (H4 207/2005).

Results: Tissue CRP, C1q, C3c and dsDNA were found to co-localize with IgG in renal subendothelial electron dense deposits. Disease controls only showed negligible staining for the tissue markers as compared with lupus nephritis and none had detectable anti-C1q, anti-CRP or anti-nucleosome antibodies. All SLE patients had circulating anti-nucleosome antibodies, and four of five were anti-CRP, anti-dsDNA, and anti-C1q antibody positive at the time of biopsy/flare. Using accumulated data (pre–post nephritis), one could observe that anti-nucleosome and anti-C1q antibody levels were more interrelated (r=0.42, p=0.046) than were the levels of anti-CRP versus anti-C1q or anti-nucleosome antibodies, respectively.

Conclusion: The results support the notion of a pathogenic role not only for antibodies directed against dsDNA, but also for anti-CRP and anti-C1q in lupus nephritis. The glomerular ICs may have been generated by deposition of circulating ICs or by in situ IC formation. The demonstrated correlation between anti-C1q and anti-nucleosome antibodies, but not between these autoantibodies and anti-CRP, indicate that the latter may reflect an independent role in the pathogenesis of lupus nephritis.


Disclosure:

C. Sjöwall,
None;

A. I. Olin,
None;

T. Skogh,
None;

J. Wetterö,
None;

M. Mörgelin,
None;

O. Nived,
None;

G. Sturfelt,
None;

A. A. Bengtsson,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/co-localization-of-c-reactive-protein-immunoglobulin-g-and-complement-in-renal-subendothelial-immune-deposits-of-proliferative-lupus-nephritis-detected-using-immunogold-electron-microscopy/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology